FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT ANVAENDBAR KRISTALLFORM ÇAÇAV 1-BENZHYDYL-4 -ALLYLPIPERAZINDIHYDROKLORID
A novel anhydrous crystalline form of 1-benzhydryl-4-allylpiperazine dihydrochloride which possesses absorption bands in its IR-spectra (tablets with nujol mulls) at 646 and 665 cm , a ratio A646/A661 = 0.6, a specific triplet at 915, 926 and 952 cm , a ratio A926/A952 = 0.8, absence of a band at 33...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | fin |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A novel anhydrous crystalline form of 1-benzhydryl-4-allylpiperazine dihydrochloride which possesses absorption bands in its IR-spectra (tablets with nujol mulls) at 646 and 665 cm , a ratio A646/A661 = 0.6, a specific triplet at 915, 926 and 952 cm , a ratio A926/A952 = 0.8, absence of a band at 3380 cm and a strongest X-ray diffraction band at 27.4 2 theta , corresponding to 37.8 nm and good water solubility properties rendering it suitable for use in preparation for sterile injectable solutions is prepared by acidifying solutions of 1-benzhydryl-4-allylpiperazine in aqueous alcoholic media. |
---|